Orchard Therapeutics (ORTX) stock price, revenue, and financials

Orchard Therapeutics market cap is $423.3 m, and annual revenue was £1.66 m in FY 2018

$423.3 M

ORTX Mkt cap, 15-Jul-2021

£1.7 M

Orchard Therapeutics Revenue FY, 2018
Orchard Therapeutics Gross profit (FY, 2018)1.3 M
Orchard Therapeutics Gross profit margin (FY, 2018), %79.7%
Orchard Therapeutics Net income (FY, 2018)-184.4 M
Orchard Therapeutics EBIT (FY, 2018)-188 M
Orchard Therapeutics Cash, 31-Dec-2018268.7 M
Orchard Therapeutics EV154.6 M
Get notified regarding key financial metrics and revenue changes at Orchard TherapeuticsLearn more
Banner background

Orchard Therapeutics Income Statement

Annual

GBPFY, 2018

Revenue

1.7m

Cost of goods sold

337.6k

Gross profit

1.3m

Gross profit Margin, %

80%

EBIT

(188.0m)

EBIT margin, %

(11321%)

Interest income

892.8k

Pre tax profit

(183.6m)

Income tax expense

776.0k

Net Income

(184.4m)

Orchard Therapeutics Balance Sheet

Annual

GBPFY, 2017FY, 2018

Cash

71.9m268.7m

Accounts Receivable

997.6k1.7m

Current Assets

75.4m284.4m

PP&E

2.2m4.4m

Total Assets

77.8m292.8m

Accounts Payable

3.1m14.5m

Current Liabilities

8.6m38.3m

Non-Current Liabilities

107.2k5.4m

Total Liabilities

8.7m43.8m

Common Stock

108.2m8.7m

Retained Earnings

(47.8m)(232.2m)

Total Equity

69.1m249.1m

Financial Leverage

1.1 x1.2 x

Orchard Therapeutics Cash Flow

Annual

GBPFY, 2017FY, 2018

Cash From Operating Activities

(26.0m)(78.0m)

Cash From Investing Activities

(1.2m)(3.2m)

Cash From Financing Activities

92.6m283.9m

Net Change in Cash

65.3m202.6m

Orchard Therapeutics Ratios

GBPFY, 2017

Financial Leverage

1.1 x

Orchard Therapeutics Employee Rating

3.818 votes
Culture & Values
4
Work/Life Balance
3.7
Senior Management
3.7
Salary & Benefits
3.9
Career Opportunities
3.6
Source